Novo Nordisk sues Hims & Hers over patent infringement
Published by Global Banking & Finance Review®
Posted on February 9, 2026
1 min readLast updated: February 9, 2026
Published by Global Banking & Finance Review®
Posted on February 9, 2026
1 min readLast updated: February 9, 2026
Novo Nordisk has initiated a lawsuit against Hims & Hers, alleging patent infringement. This legal action highlights ongoing patent disputes in the pharmaceutical sector.
COPENHAGEN, Feb 9 (Reuters) - Novo Nordisk said on Monday it has filed a lawsuit against U.S. telehealth company Hims & Hers for infringing on the Danish group's patents.
(Reporting by Stine Jacobsen, editing by Terje Solsvik)
Patent infringement occurs when someone makes, uses, sells, or distributes a patented invention without permission from the patent holder.
A technology patent protects inventions related to technology, such as software, hardware, or processes, ensuring the inventor has exclusive rights to their innovation.
Explore more articles in the Finance category



